Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival

Recent studies suggest that inflammation response biomarkers are prognostic indicators of solid tumor outcomes. Here, we quantify the prognostic value of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in glioblastomas (GBMs), taki...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Wang, Peng-Fei, Song, Hong-Wang, Cai, Hong-Qing, Kong, Ling-Wei, Yao, Kun, Jiang, Tao, Li, Shou-Wei, Yan, Chang-Xiang
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564834/
https://ncbi.nlm.nih.gov/pubmed/28223536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15235
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares